EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
Clinical trial NCT01485848 · COMPLETED
Trial details
- NCT number
- NCT01485848
- Sponsor
- Esperance Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.